<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Single-Page Interactive Diabetes Guide</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <style>
        body { font-family: 'Inter', sans-serif; }
        .tab-button { transition: all 0.3s ease; }
        .tab-button.active { background-color: #06b6d4; color: white; }
        .complication-dot { position: absolute; width: 20px; height: 20px; background-color: rgba(6, 182, 212, 0.7); border-radius: 50%; cursor: pointer; transition: all 0.3s ease; display: flex; align-items: center; justify-content: center; }
        .complication-dot:hover { transform: scale(1.2); background-color: rgba(8, 145, 178, 1); }
        .complication-dot.active { transform: scale(1.2); background-color: rgba(8, 145, 178, 1); }
        .chart-container { position: relative; width: 100%; max-width: 600px; margin-left: auto; margin-right: auto; height: 350px; max-height: 40vh; }
        @media (min-width: 768px) { .chart-container { height: 400px; } }
        .fade-in { animation: fadeIn 0.5s ease-in-out; }
        @keyframes fadeIn { from { opacity: 0; transform: translateY(10px); } to { opacity: 1; transform: translateY(0); } }
        .prose strong { color: #0891b2; } /* Highlight key terms in prose */
        /* Chat specific styles */
        #chat-window {
            height: 400px;
            overflow-y: auto;
            border: 1px solid #e2e8f0;
            border-radius: 0.75rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #f8fafc;
            display: flex;
            flex-direction: column;
            gap: 0.75rem;
        }
        .user-message {
            background-color: #dbeafe;
            color: #1e40af;
            align-self: flex-end;
            padding: 0.75rem 1rem;
            border-radius: 1.25rem 1.25rem 0.25rem 1.25rem;
            max-width: 80%;
        }
        .ai-message {
            background-color: #e0f2fe;
            color: #0891b2;
            align-self: flex-start;
            padding: 0.75rem 1rem;
            border-radius: 1.25rem 1.25rem 1.25rem 0.25rem;
            max-width: 80%;
        }
        #chat-input {
            resize: vertical;
            min-height: 60px;
        }
        #loading-indicator {
            display: none;
            text-align: center;
            padding: 0.5rem;
            color: #64748b;
        }
        /* Google Translate specific styles */
        #google_translate_element {
            margin-left: auto;
            margin-right: auto;
        }
        .goog-te-gadget-simple {
            border: 1px solid #ccc;
            border-radius: 0.5rem;
            padding: 0.25rem 0.5rem;
            background-color: #f8fafc;
        }
    </style>
</head>
<body class="bg-slate-50 text-slate-800">

    <!-- Google Translate Widget -->
    <header class="bg-white/80 backdrop-blur-lg shadow-sm sticky top-0 z-50 py-2">
        <div class="container mx-auto px-4 flex items-center justify-between">
            <h1 class="text-lg md:text-xl font-bold text-cyan-700">Diabetes Guide</h1>
            <div id="google_translate_element"></div>
        </div>
    </header>

    <main class="container mx-auto p-4 md:p-8">
        
        <section id="welcome" class="mb-12">
             <div class="max-w-4xl mx-auto">
                <h1 class="text-3xl md:text-4xl font-bold text-slate-800 mb-4 text-center">Diabetes: Overview and Global Impact</h1>
                <div class="bg-white p-6 md:p-8 rounded-2xl shadow-lg border border-slate-200 text-left mb-8">
                    <p class="text-lg text-slate-600 mb-6">Diabetes is a **chronic health condition** that affects how your body turns food into energy. Here's a clear breakdown of key information:</p>

                    <h3 class="text-2xl font-bold text-cyan-800 mb-4">1. The Core Problem</h3>
                    <ul class="list-disc list-inside space-y-2 text-slate-700 mb-6">
                        <li>Your body struggles to regulate **blood sugar (glucose)** levels.</li>
                        <li>**Insulin** (a hormone made by the pancreas) is either:
                            <ul class="list-circle list-inside ml-4 space-y-1">
                                <li>**Not produced** (Type 1 diabetes),</li>
                                <li>**Not used effectively** (Type 2 diabetes), or</li>
                                <li>**Blocked by pregnancy hormones** (Gestational diabetes).</li>
                            </ul>
                        </li>
                    </ul>

                    <h3 class="text-2xl font-bold text-cyan-800 mb-4">2. Main Types</h3>
                    <ul class="list-disc list-inside space-y-2 text-slate-700 mb-6">
                        <li>**Type 1 Diabetes:**
                            <ul class="list-circle list-inside ml-4 space-y-1">
                                <li>Autoimmune disease (body attacks insulin-producing cells).</li>
                                <li>Usually diagnosed in children/young adults.</li>
                                <li>Requires **lifelong insulin injections/pump**.</li>
                            </ul>
                        </li>
                        <li>**Type 2 Diabetes:**
                            <ul class="list-circle list-inside ml-4 space-y-1">
                                <li>Body becomes resistant to insulin or doesn't make enough.</li>
                                <li>Strongly linked to obesity, inactivity, genetics.</li>
                                <li>Managed with diet, exercise, oral meds, and sometimes insulin.</li>
                            </ul>
                        </li>
                        <li>**Gestational Diabetes:**
                            <ul class="list-circle list-inside ml-4 space-y-1">
                                <li>Occurs during pregnancy (increases risk of Type 2 later).</li>
                                <li>Managed with diet/exercise; may require medication.</li>
                            </ul>
                        </li>
                        <li>**Prediabetes:**
                            <ul class="list-circle list-inside ml-4 space-y-1">
                                <li>Blood sugar higher than normal but not yet diabetic.</li>
                                <li>Reversible with lifestyle changes.</li>
                            </ul>
                        </li>
                    </ul>

                    <h3 class="text-2xl font-bold text-cyan-800 mb-4">3. Common Symptoms</h3>
                    <ul class="list-disc list-inside space-y-2 text-slate-700 mb-6">
                        <li>Excessive thirst/hunger</li>
                        <li>Frequent urination</li>
                        <li>Unexplained weight loss (Type 1)</li>
                        <li>Fatigue</li>
                        <li>Blurred vision</li>
                        <li>Slow-healing sores</li>
                        <li>Tingling in hands/feet (*neuropathy*)</li>
                    </ul>

                    <h3 class="text-2xl font-bold text-cyan-800 mb-4">4. Treatment & Management</h3>
                    <ul class="list-disc list-inside space-y-2 text-slate-700 mb-6">
                        <li>**Lifestyle:**
                            <ul class="list-circle list-inside ml-4 space-y-1">
                                <li>**Diet (What to eat):** Low refined carbs, high fiber, controlled portions. Emphasize fruits, vegetables, lean proteins, whole grains.</li>
                                <li>**Exercise:** 150+ mins/week of moderate activity.</li>
                                <li>**Weight Management:** Crucial for Type 2 prevention/control.</li>
                            </ul>
                        </li>
                        <li>**Medical Therapy:**
                            <ul class="list-circle list-inside ml-4 space-y-1">
                                <li>**Medication:** Insulin (for Type 1, some Type 2), metformin, SGLT2 inhibitors, GLP-1 agonists, etc.</li>
                                <li>**Blood Sugar Monitoring:** Regular checks (glucometer/CGM).</li>
                            </ul>
                        </li>
                    </ul>

                    <h3 class="text-2xl font-bold text-cyan-800 mb-4">5. Potential Complications</h3>
                    <p class="text-slate-700 mb-2">(If poorly managed)</p>
                    <ul class="list-disc list-inside space-y-2 text-slate-700 mb-6">
                        <li>Heart disease/stroke</li>
                        <li>Kidney damage (*nephropathy*)</li>
                        <li>Nerve damage (*neuropathy*)</li>
                        <li>Eye damage → blindness (*retinopathy*)</li>
                        <li>Foot ulcers → amputation</li>
                        <li>Dental/gum disease</li>
                    </ul>

                    <h3 class="text-2xl font-bold text-cyan-800 mb-4">6. Key Prevention Strategies</h3>
                    <ul class="list-disc list-inside space-y-2 text-slate-700 mb-6">
                        <li>**Type 1:** Not preventable (autoimmune).</li>
                        <li>**Type 2 & Prediabetes:**
                            <ul class="list-circle list-inside ml-4 space-y-1">
                                <li>✅ Healthy weight</li>
                                <li>✅ Regular physical activity</li>
                                <li>✅ Balanced diet (limit sugar/processed foods)</li>
                                <li>✅ Avoid tobacco/excess alcohol</li>
                            </ul>
                        </li>
                    </ul>
                    <p class="text-base text-slate-600 font-semibold italic">Important Note:</p>
                    <p class="text-base text-slate-600 mb-6">Diabetes management is highly individualized. **Always work with your healthcare team** (endocrinologist, dietitian, diabetes educator) for personalized plans. Early diagnosis and consistent control dramatically reduce complications.</p>
                    <p class="text-lg text-slate-600 mb-6">Diabetes mellitus is a chronic metabolic disease marked by high blood sugar (hyperglycemia) due to defects in insulin production, secretion, or action. Uncontrolled diabetes can damage the eyes, kidneys, nerves, heart and other organs, and is among the top 10 global causes of death. Its prevalence has risen dramatically over decades – about <strong>590 million</strong> adults worldwide (20–79 years) live with diabetes (≈11.1% of adults). This burden is expected to grow further: for example, IDF projects ~853 million cases by 2050. The disease exacts a heavy toll: around <strong>6.7 million</strong> people die from diabetes each year, and global health expenditures on diabetes were an estimated <strong>$966 billion</strong> in 2021, rising toward $1 trillion by 2045. In 2024, the Western Pacific and South-East Asian regions already bear the largest case counts (215m and 107m adults, respectively). These figures underscore the enormous public health and economic impact of diabetes worldwide. Patients with diabetes often check blood glucose via fingerstick or continuous monitors to guide therapy. Diabetes management centers on tight glucose control to prevent complications. Key global statistics include: about <strong>590 million</strong> adults have diabetes (1 in 9), with over 4 in 5 cases in low/middle-income countries. Nearly half of people with diabetes remain undiagnosed. By 2050, adult diabetes prevalence is projected to reach roughly <strong>853 million</strong> worldwide. These trends highlight diabetes as a major and growing global health challenge.</p>
                </div>
            </div>
            <div class="bg-white p-6 md:p-8 rounded-2xl shadow-lg border border-slate-200">
                <h3 class="text-2xl font-bold text-cyan-800 mb-4">I. Core Pathophysiology</h3>
                <div class="prose prose-slate max-w-none text-slate-700">
                    <p><strong>Glucose Metabolism Breakdown:</strong></p>
                    <ul class="list-disc list-inside space-y-1 mb-4">
                        <li>Food &rarr; Glucose &rarr; Bloodstream &rarr; Insulin "key" unlocks cells for glucose entry.</li>
                        <li><strong>Diabetes = Locked cells</strong> (insulin resistance) <strong>or no keys</strong> (insulin deficiency).</li>
                    </ul>
                    <p class="mb-4"><strong>Pancreatic Role:</strong> Beta cells (islets of Langerhans) produce insulin. These are either destroyed (Type 1) or become exhausted (Type 2).</p>
                </div>
                <p class="text-slate-600 max-w-3xl mx-auto mb-6">This interactive diagram shows how the process is supposed to work and what goes wrong in diabetes.</p>
                <div class="grid md:grid-cols-2 gap-8 items-center">
                    <div id="insulin-diagram" class="relative w-full h-64 bg-slate-100 rounded-xl p-4 flex flex-col justify-center items-center transition-all duration-500">
                        <div class="absolute top-2 left-2 text-sm font-semibold text-slate-500">Bloodstream</div>
                        <div id="glucose-particle" class="absolute top-1/2 left-1/4 w-8 h-8 bg-yellow-400 rounded-full flex items-center justify-center font-bold text-yellow-800 shadow-md transition-all duration-1000">G</div>
                        <div id="insulin-key" class="absolute top-1/2 left-1/3 w-10 h-5 bg-cyan-500 rounded-full rounded-r-none flex items-center justify-center font-bold text-white shadow-md transition-all duration-1000">I</div>
                        <div id="cell-wall" class="absolute top-1/4 right-0 h-1/2 w-1/2 bg-white border-4 border-slate-300 rounded-lg flex flex-col justify-center items-center transition-all duration-500">
                            <span class="text-xl font-bold text-slate-500">CELL</span>
                            <span class="text-sm text-slate-400">(Needs Energy)</span>
                            <div id="cell-lock" class="absolute left-[-10px] top-1/2 -translate-y-1/2 w-5 h-8 bg-slate-400 rounded-sm transition-all duration-500"></div>
                        </div>
                    </div>
                    <div>
                        <p id="diagram-explanation" class="text-slate-600 mb-4 text-left transition-all duration-500">Press the button to see how insulin unlocks the cell for glucose.</p>
                        <button id="simulate-insulin-btn" class="w-full bg-cyan-600 text-white font-bold py-3 px-4 rounded-lg hover:bg-cyan-700 focus:outline-none focus:ring-2 focus:ring-offset-2 focus:ring-cyan-500 transition-all duration-300">
                            Simulate Insulin Action
                        </button>
                        <div id="diabetes-state-info" class="mt-4 text-left p-4 bg-amber-50 border border-amber-200 rounded-lg hidden">
                            <h4 class="font-bold text-amber-800">In Diabetes:</h4>
                            <p class="text-sm text-amber-700">Either the insulin 'key' is missing (Type 1) or the cell's 'lock' is broken (Type 2). Glucose gets stuck in the bloodstream, starving the cells of energy.</p>
                        </div>
                    </div>
                </div>
            </div>
        </section>

        <section id="types" class="mt-12 mb-12">
            <div class="text-center mb-8">
                <h2 class="text-3xl md:text-4xl font-bold text-slate-800 mb-2">II. Types & Causes</h2>
                <p class="text-lg text-slate-600 max-w-3xl mx-auto">Diabetes is broadly classified by cause and onset. Each type differs in cause, presentation, and management. Select a type below to explore its unique characteristics, causes, symptoms, diagnosis, and treatment approaches.</p>
                 <div class="bg-white p-6 md:p-8 rounded-2xl shadow-lg border border-slate-200 text-left mt-8">
                    <h3 class="text-2xl font-bold text-cyan-800 mb-4">Overview of Types and Causes</h3>
                    <div class="overflow-x-auto mb-6">
                        <table class="min-w-full bg-white border border-slate-300 rounded-lg">
                            <thead>
                                <tr class="bg-slate-100">
                                    <th class="py-3 px-4 text-left text-sm font-semibold text-slate-700 border-b">Type</th>
                                    <th class="py-3 px-4 text-left text-sm font-semibold text-slate-700 border-b">Cause</th>
                                    <th class="py-3 px-4 text-left text-sm font-semibold text-slate-700 border-b">Onset</th>
                                    <th class="py-3 px-4 text-left text-sm font-semibold text-slate-700 border-b">Key Risk Factors</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr><td class="py-2 px-4 border-b border-slate-200"><strong>Type 1</strong></td><td class="py-2 px-4 border-b border-slate-200">Autoimmune beta-cell destruction</td><td class="py-2 px-4 border-b border-slate-200">Sudden (any age)</td><td class="py-2 px-4 border-b border-slate-200">Genetics, viral triggers</td></tr>
                                <tr><td class="py-2 px-4 border-b border-slate-200"><strong>Type 2</strong></td><td class="py-2 px-4 border-b border-slate-200">Insulin resistance + progressive beta-cell loss</td><td class="py-2 px-4 border-b border-slate-200">Gradual (adults)</td><td class="py-2 px-4 border-b border-slate-200">Obesity, inactivity, genetics</td></tr>
                                <tr><td class="py-2 px-4 border-b border-slate-200"><strong>Gestational</strong></td><td class="py-2 px-4 border-b border-slate-200">Pregnancy hormones blocking insulin</td><td class="py-2 px-4 border-b border-slate-200">2nd/3rd trimester</td><td class="py-2 px-4 border-b border-slate-200">PCOS, prior GD, obesity</td></tr>
                                <tr><td class="py-2 px-4 border-b border-slate-200"><strong>MODY/LADA</strong></td><td class="py-2 px-4 border-b border-slate-200">Genetic mutations (MODY) or slow Type 1 (LADA)</td><td class="py-2 px-4 border-b border-slate-200">Varies</td><td class="py-2 px-4 border-b border-slate-200">Family history</td></tr>
                            </tbody>
                        </table>
                    </div>
                </div>
            </div>
            <div class="bg-white p-4 sm:p-6 rounded-2xl shadow-lg border border-slate-200">
                <div class="flex flex-wrap justify-center gap-2 mb-6">
                    <button data-type="type1" class="type-tab-button tab-button px-4 py-2 text-sm font-semibold text-slate-700 bg-slate-100 rounded-full hover:bg-cyan-100">Type 1</button>
                    <button data-type="type2" class="type-tab-button tab-button px-4 py-2 text-sm font-semibold text-slate-700 bg-slate-100 rounded-full hover:bg-cyan-100 active">Type 2</button>
                    <button data-type="gestational" class="type-tab-button tab-button px-4 py-2 text-sm font-semibold text-slate-700 bg-slate-100 rounded-full hover:bg-cyan-100">Gestational</button>
                    <button data-type="other" class="type-tab-button tab-button px-4 py-2 text-sm font-semibold text-slate-700 bg-slate-100 rounded-full hover:bg-cyan-100">Other Forms</button>
                </div>
                <div id="type-content-area" class="fade-in"></div>
            </div>
        </section>

        <section id="diagnosis" class="mt-12 mb-12">
            <div class="text-center mb-8">
                <h2 class="text-3xl md:text-4xl font-bold text-slate-800 mb-2">III. Symptoms and Diagnosis</h2>
                <p class="text-lg text-slate-600 max-w-3xl mx-auto">Common signs include feeling very thirsty, needing to urinate often, feeling tired, and having blurred vision. If not managed, diabetes can lead to serious issues like heart disease, kidney failure, blindness, and nerve damage. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) emphasizes that many people may have no symptoms and remain undiagnosed, underscoring the importance of screening.</p>
            </div>
            <div class="bg-white p-4 sm:p-6 rounded-2xl shadow-lg border border-slate-200">
                <div class="flex flex-col md:flex-row md:items-center md:justify-between mb-6">
                    <h3 class="text-xl font-bold text-cyan-800 mb-2 md:mb-0">Diagnostic Test Ranges</h3>
                    <div class="flex items-center gap-2">
                        <label for="test-selector" class="font-semibold text-slate-600">Select a Test:</label>
                        <select id="test-selector" class="block w-full md:w-auto p-2 border border-slate-300 rounded-md bg-white focus:outline-none focus:ring-2 focus:ring-cyan-500">
                            <option value="a1c">A1C Test (%)</option>
                            <option value="fpg">Fasting Plasma Glucose (mg/dL)</option>
                            <option value="ogtt">2-hour OGTT (mg/dL)</option>
                        </select>
                    </div>
                </div>
                <div class="chart-container">
                    <canvas id="diagnosisChart"></canvas>
                </div>
                 <div class="mt-4 text-center text-sm text-slate-500">
                    <p class="mb-2">This chart shows the values that define Normal, Prediabetes, and Diabetes ranges. Diagnosis relies on blood glucose measurements. Criteria (endorsed by the ADA) include:</p>
                    <ul class="list-disc list-inside space-y-1 text-slate-600 max-w-xl mx-auto text-left">
                        <li><strong>Fasting blood glucose ≥126 mg/dL (7.0 mmol/L)</strong> on two occasions.</li>
                        <li><strong>HbA1c ≥6.5%</strong> (reflects 2–3 month average glucose).</li>
                        <li><strong>Random glucose ≥200 mg/dL + classic symptoms</strong> also indicates diabetes.</li>
                        <li><strong>Oral Glucose Tolerance Test (OGTT) ≥200 mg/dL</strong> after a 75-g oral load.</li>
                    </ul>
                    <p class="mt-2 text-slate-600 max-w-xl mx-auto text-left"><strong>Prediabetes criteria:</strong> HbA1c 5.7–6.4% or Fasting glucose 100–125 mg/dL.</p>
                    <p class="mt-2 text-slate-500">To distinguish type 1 from type 2/LADA, clinicians may measure autoantibodies (e.g. GAD, IA-2) and C-peptide levels. Genomic tests can diagnose monogenic forms (MODY). In pregnancy, an OGTT screen is done in the late second trimester to identify GDM.</p>
                </div>
            </div>
        </section>

        <section id="management" class="mt-12 mb-12">
            <div class="text-center mb-8">
                <h2 class="text-3xl md:text-4xl font-bold text-slate-800 mb-2">IV. Advanced Management Strategies</h2>
                <p class="text-lg text-slate-600 max-w-3xl mx-auto">Managing diabetes involves a healthy diet, regular exercise, blood sugar monitoring, and medications. Regular checkups help prevent complications, and early diagnosis is key to effective management. All types of diabetes require careful glycemic control to prevent complications. Key components of management include medications, lifestyle modifications, continuous monitoring, and ongoing education and support.</p>
            </div>
            <div class="bg-white p-4 sm:p-6 rounded-2xl shadow-lg border border-slate-200">
                <h3 class="text-xl font-bold text-cyan-800 mb-4">A. Medications</h3>
                <p class="text-slate-600 mb-4">Medications are tailored to the type of diabetes and individual needs. Here are key classes:</p>
                <div class="flex flex-wrap justify-center gap-2 mb-6 border-b border-slate-200 pb-4">
                    <button data-tab="lifestyle" class="management-tab-button tab-button px-4 py-2 text-sm font-semibold text-slate-700 bg-slate-100 rounded-full hover:bg-cyan-100 active">Lifestyle</button>
                    <button data-tab="medication" class="management-tab-button tab-button px-4 py-2 text-sm font-semibold text-slate-700 bg-slate-100 rounded-full hover:bg-cyan-100">Medications (Type 2)</button>
                    <button data-tab="insulin" class="management-tab-button tab-button px-4 py-2 text-sm font-semibold text-slate-700 bg-slate-100 rounded-full hover:bg-cyan-100">Insulin Therapy & Tech</button>
                </div>
                <div id="management-content-area" class="fade-in"></div>
                 <div class="mt-6 p-4 bg-slate-100 rounded-lg text-sm text-slate-700">
                    <h4 class="font-bold text-cyan-800 mb-2">Monitoring & Support:</h4>
                    <p class="mb-2">Patients self-monitor glucose with home meters or CGMs. A1C is checked periodically (goal <7% for most adults). Frequent monitoring guides therapy adjustments to avoid both hyper- and hypoglycemia. Diabetes self-management education and support (DSMES) programs help patients learn insulin administration, diet planning, and coping strategies. Ongoing counseling increases adherence and reduces complications.</p>
                </div>
            </div>
        </section>

        <section id="complications" class="mt-12 mb-12">
             <div class="text-center mb-8">
                <h2 class="text-3xl md:text-4xl font-bold text-slate-800 mb-2">V. Acute & Chronic Complications</h2>
                <p class="text-lg text-slate-600 max-w-3xl mx-auto">Common signs include feeling very thirsty, needing to urinate often, feeling tired, and having blurred vision. If not managed, diabetes can lead to serious issues like heart disease, kidney failure, blindness, and nerve damage. Chronic hyperglycemia damages blood vessels and nerves. Diabetes doubles the risk of heart disease. It contributes to 530,000 kidney disease deaths and is linked to 1 in 2 cardiovascular deaths. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) emphasizes that many people may have no symptoms and remain undiagnosed, underscoring the importance of screening.</p>
            </div>
            <div class="bg-white p-4 sm:p-6 rounded-2xl shadow-lg border border-slate-200">
                <h3 class="text-xl font-bold text-cyan-800 mb-4">Acute Complications</h3>
                 <div class="overflow-x-auto mb-8">
                    <table class="min-w-full bg-white border border-slate-300 rounded-lg">
                        <thead>
                            <tr class="bg-slate-100">
                                <th class="py-3 px-4 text-left text-sm font-semibold text-slate-700 border-b">Condition</th>
                                <th class="py-3 px-4 text-left text-sm font-semibold text-slate-700 border-b">Cause</th>
                                <th class="py-3 px-4 text-left text-sm font-semibold text-slate-700 border-b">Symptoms</th>
                                <th class="py-3 px-4 text-left text-sm font-semibold text-slate-700 border-b">Action</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr><td class="py-2 px-4 border-b border-slate-200"><strong>Hypoglycemia</strong></td><td class="py-2 px-4 border-b border-slate-200">Too much insulin/meds, skipped meals</td><td class="py-2 px-4 border-b border-slate-200">Shakiness, confusion, sweating</td><td class="py-2 px-4 border-b border-slate-200">15g fast-acting carbs (glucose gel)</td></tr>
                            <tr><td class="py-2 px-4 border-b border-slate-200"><strong>DKA</strong> (Type 1)</td><td class="py-2 px-4 border-b border-slate-200">Severe insulin deficiency → ketones</td><td class="py-2 px-4 border-b border-slate-200">Nausea, fruity breath, coma</td><td class="py-2 px-4 border-b border-slate-200"><strong>ER: IV fluids + insulin</strong></td></tr>
                            <tr><td class="py-2 px-4 border-b border-slate-200"><strong>HHS</strong> (Type 2)</td><td class="py-2 px-4 border-b border-slate-200">Extreme hyperglycemia → dehydration</td><td class="py-2 px-4 border-b border-slate-200">Blood sugar >600 mg/dL, stupor</td><td class="py-2 px-4 border-b border-slate-200"><strong>ER: Aggressive rehydration</strong></td></tr>
                        </tbody>
                    </table>
                </div>

                <h3 class="text-xl font-bold text-cyan-800 mb-4 mt-8">Chronic Complications</h3>
                <p class="text-slate-600 mb-6">Chronic hyperglycemia damages blood vessels and nerves. Major complications include **microvascular** and **macrovascular** issues. Click on the highlighted areas of the body to learn more.</p>
                <div class="grid md:grid-cols-2 gap-8 items-start">
                    <div class="relative w-full max-w-xs mx-auto aspect-[3/5]">
                        <!-- Simple stick figure SVG for body outline -->
                        <svg viewBox="0 0 100 150" class="absolute inset-0 w-full h-full text-slate-300">
                            <circle cx="50" cy="20" r="15" fill="currentColor"/> <!-- Head -->
                            <line x1="50" y1="35" x2="50" y2="90" stroke="currentColor" stroke-width="5" stroke-linecap="round"/> <!-- Torso -->
                            <line x1="50" y1="50" x2="30" y2="70" stroke="currentColor" stroke-width="5" stroke-linecap="round"/> <!-- Left arm -->
                            <line x1="50" y1="50" x2="70" y2="70" stroke="currentColor" stroke-width="5" stroke-linecap="round"/> <!-- Right arm -->
                            <line x1="50" y1="90" x2="35" y2="140" stroke="currentColor" stroke-width="5" stroke-linecap="round"/> <!-- Left leg -->
                            <line x1="50" y1="90" x2="65" y2="140" stroke="currentColor" stroke-width="5" stroke-linecap="round"/> <!-- Right leg -->
                        </svg>
                        <!-- Position complication dots relative to this SVG's coordinates -->
                        <div data-comp="brain" class="complication-dot" style="top: 10%; left: 45%;"></div>
                        <div data-comp="eyes" class="complication-dot" style="top: 15%; left: 45%;"></div>
                        <div data-comp="heart" class="complication-dot" style="top: 35%; left: 45%;"></div>
                        <div data-comp="kidneys" class="complication-dot" style="top: 50%; left: 35%;"></div>
                        <div data-comp="kidneys" class="complication-dot" style="top: 50%; left: 55%;"></div>
                        <div data-comp="nerves" class="complication-dot" style="top: 70%; left: 35%;"></div>
                        <div data-comp="feet" class="complication-dot" style="bottom: 5%; left: 45%;"></div>
                    </div>
                    <div id="complication-info-area" class="pt-4 md:pt-0">
                         <div class="p-6 bg-slate-100 rounded-lg fade-in">
                            <h3 class="text-xl font-bold text-cyan-800 mb-2">Select a point on the diagram</h3>
                            <p class="text-slate-600">Click a flashing point on the body outline to display information about common long-term diabetes complications related to that area. Tight glucose control, along with blood pressure and lipid control, can significantly reduce these risks.</p>
                        </div>
                    </div>
                </div>
            </div>
        </section>

        <section id="future" class="mt-12 mb-12">
            <div class="text-center mb-8">
                <h2 class="text-3xl md:text-4xl font-bold text-slate-800 mb-2">VI. Emerging Research & Future Care</h2>
                <p class="text-lg text-slate-600 max-w-3xl mx-auto">As of 2025, exciting progress is reshaping diabetes treatment, particularly for type 1 diabetes, which has historically been more challenging to manage. The field of diabetes is one of the most rapidly advancing areas in medicine. A convergence of technology and biological research is changing what's possible, moving towards a future of easier management and potential cures. Collectively, these advances offer hope for better control and even prevention/cure of diabetes.</p>
            </div>
             <div class="grid md:grid-cols-2 lg:grid-cols-3 gap-6">
                <div class="bg-white p-6 rounded-xl shadow-lg border border-slate-200">
                    <h3 class="font-bold text-lg text-cyan-800 mb-2">Artificial Pancreas & Closed-Loop Systems</h3>
                    <p class="text-slate-600 text-sm">Hybrid closed-loop systems, integrating continuous glucose monitors (CGMs) and insulin pumps, are becoming standard. They automatically adjust insulin delivery, easing day-to-day control and improving outcomes (2024 approvals).</p>
                </div>
                <div class="bg-white p-6 rounded-xl shadow-lg border border-slate-200">
                    <h3 class="font-bold text-lg text-cyan-800 mb-2">Stem Cell & Beta-Cell Regeneration</h3>
                    <p class="text-slate-600 text-sm">Research shows **harmine** increasing human beta cell mass. Clinical trials are implanting stem-cell-derived β-cells encapsulated to avoid immune attack. Landmark cases have achieved insulin independence, potentially offering a functional cure.</p>
                </div>
                 <div class="bg-white p-6 rounded-xl shadow-lg border border-slate-200">
                    <h3 class="font-bold text-lg text-cyan-800 mb-2">Hypoimmune Islet Transplants</h3>
                    <p class="text-slate-600 text-sm">New approaches focus on genetically modified pluripotent stem cells for an unlimited supply of islet cells that are "hypoimmune," meaning they may not require lifelong immunosuppression after transplantation.</p>
                </div>
                 <div class="bg-white p-6 rounded-xl shadow-lg border border-slate-200">
                    <h3 class="font-bold text-lg text-cyan-800 mb-2">Smart Insulins</h3>
                    <p class="text-slate-600 text-sm">New insulin analogs with glucose-responsive mechanisms (e.g., NNC2215) activate only when needed, reducing hypoglycemia risk. These are currently in preclinical development.</p>
                </div>
                <div class="bg-white p-6 rounded-xl shadow-lg border border-slate-200">
                    <h3 class="font-bold text-lg text-cyan-800 mb-2">AI-Powered Insulin Delivery</h3>
                    <p class="text-slate-600 text-sm">Clinical trials on systems like the **Bolus Priming System with Reinforcement Learning (BPS_RL)** explore AI upgrades to improve blood sugar control during meals and overnight for diabetic adults.</p>
                </div>
                 <div class="bg-white p-6 rounded-xl shadow-lg border border-slate-200">
                    <h3 class="font-bold text-lg text-cyan-800 mb-2">Immunotherapy (Type 1)</h3>
                    <p class="text-slate-600 text-sm">The FDA-approved drug **Teplizumab (Tzield)** can delay onset of stage-3 Type 1 diabetes. Other immune therapies (anti-CD3, antigen vaccines) are in trials, aiming to halt the autoimmune attack on beta cells.</p>
                </div>
                <div class="bg-white p-6 rounded-xl shadow-lg border border-slate-200">
                    <h3 class="font-bold text-lg text-cyan-800 mb-2">Gut Microbiome & Probiotics</h3>
                    <p class="text-slate-600 text-sm">Research is exploring the role of the gut microbiome in diabetes, with probiotics targeting inflammation and improving insulin sensitivity as potential new avenues for treatment and prevention.</p>
                </div>
                <div class="bg-white p-6 rounded-xl shadow-lg border border-slate-200">
                    <h3 class="font-bold text-lg text-cyan-800 mb-2">Novel Drug Targets</h3>
                    <p class="text-slate-600 text-sm">Beyond incretin agonists and SGLT2 inhibitors, new drug targets (GPR40 agonists, hepatic glucose production inhibitors, etc.) are in research pipelines, promising more diverse treatment options.</p>
                </div>
                <div class="bg-white p-6 rounded-xl shadow-lg border border-slate-200">
                    <h3 class="font-bold text-lg text-cyan-800 mb-2">Wearable Biosensors & Digital Health</h3>
                    <p class="text-slate-600 text-sm">Beyond CGMs, new wearable biosensors are in development. Smartphone apps and telehealth platforms enhance patient monitoring and lifestyle support, improving personalized care and screening.</p>
                </div>
            </div>

            <div class="mt-12 bg-white p-6 rounded-2xl shadow-lg border border-slate-200">
                <h3 class="text-2xl font-bold text-cyan-800 mb-4 text-center">VIII. Psychological Impact</h3>
                <p class="text-slate-600 max-w-3xl mx-auto mb-6 text-center">Living with diabetes can take a significant mental and emotional toll:</p>
                <ul class="list-disc list-inside space-y-2 text-slate-700 max-w-xl mx-auto text-left">
                    <li>**Diabetes Distress**: 40% experience burnout due to the constant demands of monitoring, managing medications, and fear of complications.</li>
                    <li>**Depression**: Individuals with diabetes have a 2x higher risk of developing depression.</li>
                    <li>**Support**: Cognitive Behavioral Therapy (CBT), diabetes support groups, and integration of mental health care are crucial for addressing these challenges.</li>
                </ul>
            </div>

            <div class="mt-12 bg-white p-6 rounded-2xl shadow-lg border border-slate-200">
                <h3 class="text-2xl font-bold text-cyan-800 mb-4 text-center">IX. Prevention</h3>
                <p class="text-lg text-slate-600 max-w-3xl mx-auto mb-6 text-center">Prevention strategies are highly effective, especially for Type 2 and Gestational Diabetes:</p>
                <ul class="list-disc list-inside space-y-2 text-slate-700 max-w-xl mx-auto text-left">
                    <li>**Type 2 & Prediabetes:** <ul class="list-circle list-inside ml-4 space-y-1">
                            <li>✅ Healthy weight</li>
                            <li>✅ Regular physical activity</li>
                            <li>✅ Balanced diet (limit sugar/processed foods)</li>
                            <li>✅ Avoid tobacco/excess alcohol</li>
                        </ul>
                    </li>
                    <li>**Gestational Diabetes**: Screen at 24–28 weeks. Note that 50% of women who have had GDM develop Type 2 diabetes within 10 years post-delivery, emphasizing the importance of continued monitoring and lifestyle management.</li>
                    <li>**Type 1 Prevention**: While no proven prevention exists yet, research is ongoing into vaccines or tolerizing therapies (e.g., trials of oral insulin).</li>
                </ul>
            </div>

            <div class="mt-12 bg-white p-6 rounded-2xl shadow-lg border border-slate-200">
                <h3 class="text-2xl font-bold text-cyan-800 mb-4 text-center">X. Global Burden</h3>
                <p class="text-slate-600 mb-6 text-center">Diabetes remains a major public health burden. It disproportionately affects poorer countries (**81%** of cases in low/mid-income nations) and low-resource communities, straining health systems. The World Health Assembly has set targets (80% of people diagnosed, controlled, etc. by 2030) to reduce complications. Economically, the impact is enormous. Beyond the estimated **$966+ billion** in healthcare expenditures (2021), there are huge indirect costs: lost productivity from disability, premature death, and absenteeism. In the USA, diabetes (11.6% of the population) cost over **$413 billion** in 2022 (including $307b direct medical costs and $106b indirect). Globally, diabetes is one of the costliest chronic diseases; its burden is projected to rise as prevalence climbs. This economic strain affects families and national economies, exacerbating poverty in vulnerable populations.</p>
                <div class="overflow-x-auto mb-6">
                    <h4 class="text-xl font-bold text-cyan-800 mb-2 text-center">Regional Distribution of Adult Diabetes Cases (2024)</h4>
                    <table class="min-w-full bg-white border border-slate-300 rounded-lg">
                        <thead>
                            <tr class="bg-slate-100">
                                <th class="py-3 px-4 text-left text-sm font-semibold text-slate-700 border-b">Region</th>
                                <th class="py-3 px-4 text-left text-sm font-semibold text-slate-700 border-b">Adults (20–79) with Diabetes (2024)</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr><td class="py-2 px-4 border-b border-slate-200">Western Pacific</td><td class="py-2 px-4 border-b border-slate-200">215 million</td></tr>
                            <tr><td class="py-2 px-4 border-b border-slate-200">South-East Asia</td><td class="py-2 px-4 border-b border-slate-200">107 million</td></tr>
                            <tr><td class="py-2 px-4 border-b border-slate-200">Middle East & North Africa</td><td class="py-2 px-4 border-b border-slate-200">85 million</td></tr>
                            <tr><td class="py-2 px-4 border-b border-slate-200">Europe</td><td class="py-2 px-4 border-b border-slate-200">66 million</td></tr>
                            <tr><td class="py-2 px-4 border-b border-slate-200">North America & Caribbean</td><td class="py-2 px-4 border-b border-slate-200">56 million</td></tr>
                            <tr><td class="py-2 px-4 border-b border-slate-200">South & Central America</td><td class="py-2 px-4 border-b border-slate-200">35 million</td></tr>
                            <tr><td class="py-2 px-4 border-b border-slate-200">Africa</td><td class="py-2 px-4 border-b border-slate-200">25 million</td></tr>
                            <tr class="font-bold bg-slate-50"><td class="py-2 px-4 border-b border-slate-200">World Total</td><td class="py-2 px-4 border-b border-slate-200">589 million</td></tr>
                        </tbody>
                    </table>
                </div>
                <p class="mt-4 text-sm text-slate-500 text-center">Approximately <strong>240–250 million</strong> people worldwide have diabetes but are unaware of it. This "missing" half of cases is mostly in resource-limited settings.</p>
            </div>

            <div class="mt-12 bg-white p-6 rounded-2xl shadow-lg border border-slate-200">
                <h3 class="text-2xl font-bold text-cyan-800 mb-4 text-center">Key Takeaways</h3>
                <ul class="list-disc list-inside space-y-2 text-slate-700 max-w-xl mx-auto text-left">
                    <li>✅ <strong>Control ABCs</strong>: A1c <7%, Blood pressure <140/90, Cholesterol (LDL <100 mg/dL).</li>
                    <li>✅ <strong>Screen Early</strong>: Annual checks if overweight + 1 risk factor.</li>
                    <li>✅ <strong>Tech is Transformative</strong>: CGM improves HbA1c more than fingersticks.</li>
                </ul>
                <p class="mt-4 text-lg text-slate-600 max-w-3xl mx-auto text-center">**Critical**: Diabetes is *manageable*. Tight control prevents/delays complications by **60%** (UKPDS/DCCT trials).</p>
            </div>


            <div class="mt-12 bg-white p-6 rounded-2xl shadow-lg border border-slate-200">
                <h3 class="text-2xl font-bold text-cyan-800 mb-4 text-center">Detailed Survey Note on Diabetes</h3>
                <div class="prose prose-slate max-w-none text-slate-700 text-left overflow-y-auto max-h-96 p-4 border border-slate-200 rounded-lg bg-slate-50">
                    <p>Diabetes, a chronic metabolic disorder characterized by elevated blood glucose levels, affects over <strong>537 million</strong> people globally, with projections suggesting a rise to <strong>15-17 million</strong> cases of Type 1 diabetes by 2040. This note provides a comprehensive overview, drawing from recent data and research as of June 7, 2025, to ensure a thorough understanding for both general readers and those seeking detailed insights.</p>
                    <h4>Background and Prevalence</h4>
                    <p>Diabetes occurs when the pancreas fails to produce sufficient insulin or when the body cannot effectively utilize the insulin it produces, leading to hyperglycemia. According to the World Health Organization (WHO), in 2022, <strong>14%</strong> of adults aged 18 and older were living with diabetes, up from <strong>7%</strong> in 1990, highlighting a significant global health challenge. The WHO also notes that <strong>59%</strong> of adults aged 30 and over with diabetes were not taking medication in 2022, with treatment coverage lowest in low- and middle-income countries. In 2021, diabetes directly caused <strong>1.6 million</strong> deaths, with <strong>47%</strong> occurring before age 70, and contributed to <strong>530,000</strong> kidney disease deaths and <strong>11%</strong> of cardiovascular deaths due to high blood glucose. Since 2000, diabetes mortality rates have increased, though the probability of dying from diabetes between ages 30-70 decreased by <strong>20%</strong> globally between 2000-2019.</p>
                    <h4>Types of Diabetes</h4>
                    <p>Diabetes is classified into several types, each with distinct characteristics:</p>
                    <ul>
                        <li><strong>Type 1 Diabetes</strong>: An autoimmune condition where the pancreas produces little or no insulin, requiring daily insulin injections for survival. It affected <strong>9 million</strong> people in 2017, predominantly in high-income countries, with causes and prevention still unknown. It is often diagnosed in children and young adults but can occur at any age.</li>
                        <li><strong>Type 2 Diabetes</strong>: The most common form, accounting for over <strong>95%</strong> of cases, occurs when the body becomes resistant to insulin or doesn't produce enough. Formerly known as non-insulin-dependent or adult-onset diabetes, it is now increasingly seen in children due to rising obesity rates. It is often preventable, linked to overweight, lack of exercise, and genetics.</li>
                        <li><strong>Gestational Diabetes</strong>: Diagnosed via prenatal screening, this type involves hyperglycemia during pregnancy, increasing risks of complications during delivery and future type 2 diabetes for both mother and child. It typically resolves post-pregnancy but requires monitoring.</li>
                        <li><strong>Impaired Glucose Tolerance (IGT) and Impaired Fasting Glycaemia (IFG)</strong>: These are intermediate conditions with a high risk of progressing to type 2 diabetes, though progression is not inevitable, offering opportunities for intervention.</li>
                    </ul>
                    <p>A recent development, as noted by the International Diabetes Federation (IDF), is the formal classification and launch of a working group for "type 5 diabetes," linked to malnutrition, indicating evolving understandings of diabetes subtypes.</p>
                    <h4>Symptoms and Complications</h4>
                    <p>Symptoms can be sudden in type 1 diabetes and mild in type 2, sometimes taking years to notice. They include:</p>
                    <ul>
                        <li>Feeling very thirsty (polydipsia)</li>
                        <li>Needing to urinate more often (polyuria)</li>
                        <li>Blurred vision</li>
                        <li>Feeling tired</li>
                        <li>Unintentional weight loss</li>
                    </ul>
                    <p>Over time, uncontrolled diabetes damages blood vessels, affecting the heart, eyes, kidneys, and nerves, increasing risks of heart attack, stroke, kidney failure, vision loss, foot ulcers, and amputation. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) emphasizes that many people may have no symptoms and remain undiagnosed, underscoring the importance of screening.</p>
                    <h4>Treatment and Management</h4>
                    <p>Treatment strategies aim to manage blood glucose levels and prevent complications, tailored to the diabetes type:</p>
                    <ul>
                        <li><strong>General Approaches</strong>: Can be treated with diet, physical activity, medication, and regular screening for complications to avoid or delay consequences. The American Diabetes Association (ADA) highlights the importance of healthy lifestyle changes for managing diabetes effectively.</li>
                        <li><strong>Type 1 Diabetes</strong>: Requires insulin injections for survival, with no current cure, though research is advancing toward potential regenerative therapies.</li>
                        <li><strong>Type 2 Diabetes</strong>: May involve medications like metformin, sulfonylureas, SGLT-2 inhibitors, alongside blood pressure medications and statins. Lifestyle modifications, including weight loss and increased activity, are crucial, with the NIDDK noting that type 2 diabetes can be prevented or delayed by losing weight if overweight, being active for 30 minutes most days, and following a reduced-calorie eating plan.</li>
                        <li><strong>Additional Care</strong>: Includes foot care to prevent ulcers, kidney disease screening and treatment, and eye exams for retinopathy. Early diagnosis via inexpensive blood glucose testing is emphasized by the WHO as critical for effective management.</li>
                    </ul>
                    <h4>Recent Developments and Breakthroughs</h4>
                    <p>As of 2025, several promising advancements are reshaping diabetes treatment, particularly for type 1 diabetes, which has historically been more challenging to manage:</p>
                    <ul>
                        <li><strong>Beta Cell Regeneration with Harmine</strong>: Research at Icahn School of Medicine at Mount Sinai shows harmine increasing human beta cell mass by 300% alone and by 700% with GLP-1 in mice, with ongoing clinical studies planned. This could revolutionize treatment by regenerating insulin-producing cells.</li>
                        <li><strong>Hypoimmune Islet Cell Transplantation</strong>: Sana Biotechnology announced positive results in a first successful donor-derived transplant in an immune-competent individual. The patient, after 30 years, began producing their own insulin, with next steps involving genetically modified pluripotent stem cells for an unlimited supply, potentially eliminating the need for immunosuppression.</li>
                        <li><strong>Patient-Specific Cell Therapy</strong>: HongKui Deng at Peking University used a patient's own cells, chemically reprogrammed into islet cells, achieving insulin independence by day 75 in a 25-year-old patient, maintained at 1-year follow-up, offering a personalized approach.</li>
                        <li><strong>AI-Powered Insulin Delivery</strong>: The University of Virginia is conducting a clinical trial on the Bolus Priming System with Reinforcement Learning (BPS_RL), comparing blood sugar levels in 16 diabetic adults with and without AI upgrades, aiming to improve control during meals and overnight.</li>
                    </ul>
                    <p>Additionally, the ADA released the Standards of Care in Diabetes—2025, incorporating new guidance on diabetes technology and monitoring, while articles like Forbes highlight these breakthroughs as part of a new era of hope. The 2025 guidelines emphasize expanded technology use, and updates from the ATTD 2025 conference showcased advancements in T1D cell therapies and early detection.</p>
                    <h4>Risk Factors and Prevention</h4>
                    <p>Risk factors vary by type. For type 2 diabetes, the NIDDK lists family history, overweight or obesity, age 35 or older, physical inactivity, race, ethnicity, and certain health conditions as increasing risk, with a history of gestational diabetes posing risks for both parent and child. Prevention strategies include weight loss, regular activity, and a reduced-calorie diet, particularly effective for delaying type 2 diabetes onset.</p>
                    <h4>Global and Economic Impact</h4>
                    <p>The economic burden is significant, with diabetes treatment coverage lowest in low- and middle-income countries, as per WHO data. The Global Diabetes Compact webpage outlines efforts to improve access, while the GBD Results Tool provides detailed statistics on diabetes prevalence and mortality.</p>
                    <h4>Table: Summary of Diabetes Types and Key Characteristics</h4>
                    <div class="overflow-x-auto">
                        <table class="min-w-full bg-white border border-slate-300 rounded-lg">
                            <thead>
                                <tr class="bg-slate-100">
                                    <th class="py-3 px-4 text-left text-sm font-semibold text-slate-700 border-b">Type</th>
                                    <th class="py-3 px-4 text-left text-sm font-semibold text-slate-700 border-b">Cause</th>
                                    <th class="py-3 px-4 text-left text-sm font-semibold text-slate-700 border-b">Typical Onset</th>
                                    <th class="py-3 px-4 text-left text-sm font-semibold text-slate-700 border-b">Treatment Focus</th>
                                    <th class="py-3 px-4 text-left text-sm font-semibold text-slate-700 border-b">Prevalence Notes</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr><td class="py-2 px-4 border-b border-slate-200">Type 1 Diabetes</td><td class="py-2 px-4 border-b border-slate-200">Autoimmune, no insulin production</td><td class="py-2 px-4 border-b border-slate-200">Childhood/Young Adult</td><td class="py-2 px-4 border-b border-slate-200">Insulin injections, monitoring</td><td class="py-2 px-4 border-b border-slate-200">9 million in 2017, high-income focus</td></tr>
                                <tr><td class="py-2 px-4 border-b border-slate-200">Type 2 Diabetes</td><td class="py-2 px-4 border-b border-slate-200">Insulin resistance, insufficient production</td><td class="py-2 px-4 border-b border-slate-200">Adults, increasingly children</td><td class="py-2 px-4 border-b border-slate-200">Lifestyle, medications (metformin, etc.)</td><td class="py-2 px-4 border-b border-slate-200">>95% of cases, preventable</td></tr>
                                <tr><td class="py-2 px-4 border-b border-slate-200">Gestational Diabetes</td><td class="py-2 px-4 border-b border-slate-200">Hyperglycemia during pregnancy</td><td class="py-2 px-4 border-b border-slate-200">Pregnancy</td><td class="py-2 px-4 border-b border-slate-200">Monitoring, often resolves post-birth</td><td class="py-2 px-4 border-b border-slate-200">Increases future Type 2 risk</td></tr>
                            </tbody>
                        </table>
                    </div>
                    <h4>Key Citations</h4>
                    <ul class="list-disc list-inside space-y-1 text-slate-600">
                        <li>Beta Cell Regeneration Study</li>
                        <li>Harmine Research</li>
                        <li>Sana Biotechnology Results</li>
                        <li>Patient-Specific Therapy</li>
                        <li>UVA Clinical Trial</li>
                        <li>Emerging Breakthroughs</li>
                        <li>ADA Standards 2025</li>
                        <li>ATTD 2025 Updates</li>
                        <li>WHO Global Diabetes Compact</li>
                        <li>GBD Results</li>
                        <li>Diabetes Overview</li>
                        <li>About Diabetes</li>
                        <li>Diabetes Factsheet</li>
                    </ul>
                </div>
            </div>
        </section>

        <!-- New AI Chat Section -->
        <section id="ai-chat" class="mt-12 mb-12 max-w-4xl mx-auto bg-white p-6 md:p-8 rounded-2xl shadow-lg border border-slate-200">
            <h2 class="text-3xl md:text-4xl font-bold text-cyan-800 mb-6 text-center">Ask Our AI Assistant</h2>
            <p class="text-slate-600 mb-4 text-center">Get quick information on the latest diabetes treatments, self-management, and how to stay updated on research.</p>
            
            <div id="chat-window" class="w-full">
                <div class="ai-message text-sm">Hello! I'm here to help you with information on diabetes treatments and self-management. What would you like to know?</div>
            </div>

            <div class="flex flex-col sm:flex-row gap-4 mt-4">
                <textarea id="chat-input" class="flex-grow p-3 border border-slate-300 rounded-lg focus:outline-none focus:ring-2 focus:ring-cyan-500 text-slate-700" placeholder="Type your question here..."></textarea>
                <button id="send-chat-btn" class="bg-cyan-600 text-white font-bold py-3 px-6 rounded-lg hover:bg-cyan-700 focus:outline-none focus:ring-2 focus:ring-offset-2 focus:ring-cyan-500 transition-all duration-300">
                    Send
                </button>
            </div>
            <div id="loading-indicator" class="text-sm mt-2 hidden">Thinking...</div>
        </section>

    </main>
    
    <footer class="bg-slate-800 text-white mt-12">
        <div class="container mx-auto p-6 text-center text-sm text-slate-400">
            <p class="mb-4">This interactive application is for educational purposes only and is based on the provided comprehensive report on Diabetes Mellitus. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.</p>
            
            <div class="grid grid-cols-1 md:grid-cols-2 gap-8 text-left mb-6">
                <div>
                    <h4 class="font-bold text-lg text-cyan-300 mb-2">Vishal Hospital</h4>
                    <p><strong>Address:</strong> Vishal Hospital, Kailashwadi Main Road, opposite Taluka Polish Choki, Junction Plot, Rajkot, Gujarat 360001</p>
                    <p><strong>Mobile Number:</strong> 9228105245</p>
                    <p><strong>Landline Number:</strong> 0281-2450408</p>
                    <p><strong>Website:</strong> <a href="https://vishalhospitalrajkot.github.io/" class="text-cyan-400 hover:underline" target="_blank">vishalhospitalrajkot.github.io</a></p>
                </div>
                <div>
                    <h4 class="font-bold text-lg text-cyan-300 mb-2">Vishal Banquet Hall</h4>
                    <p><strong>Address:</strong> Vishal Banquet Hall, Gaya-Dobhi Rd, Musatpura, Bihar 823004</p>
                    <p><strong>Mobile Number:</strong> 9228105245</p>
                    <p><strong>Website:</strong> <a href="https://vishalbanquethall1.github.io/" class="text-cyan-400 hover:underline" target="_blank">vishalbanquethall1.github.io</a></p>
                </div>
            </div>

            <p class="mt-2">&copy; 2025 Interactive Health Explainers. All Rights Reserved.</p>
        </div>
    </footer>


<script type="text/javascript">
    // Google Translate Init
    function googleTranslateElementInit() {
        new google.translate.TranslateElement({
            pageLanguage: 'en',
            includedLanguages: 'en,hi,gu,bho', // English, Hindi, Gujarati, Bhojpuri
            layout: google.translate.TranslateElement.InlineLayout.SIMPLE,
            autoDisplay: false
        }, 'google_translate_element');
    }
</script>
<script type="text/javascript" src="//translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script>

<script>
document.addEventListener('DOMContentLoaded', function () {
    const dataStore = {
        types: {
            type1: {
                title: 'Type 1 Diabetes Mellitus (T1D): An Autoimmune Condition',
                content: `<p class="mb-4">Type 1 diabetes is an autoimmune condition where the pancreas produces little or no insulin, requiring daily insulin injections for survival. It affected <strong>9 million</strong> people in 2017, predominantly in high-income countries, with causes and prevention still unknown. It is often diagnosed in children and young adults but can occur at any age. It is caused by immune destruction of pancreatic β-cells, leading to absolute insulin deficiency. <strong>Genetic susceptibility</strong> (HLA genotypes) and possible environmental triggers (viral infections) increase risk, though most new cases have no family history. No strong lifestyle factors are known, and it is not preventable by current means.</p>
                          <h4 class="font-semibold text-cyan-800 mb-2">Symptoms:</h4>
                          <p class="mb-4">Onset is often abrupt. Classic symptoms include frequent urination (polyuria), excessive thirst (polydipsia), extreme hunger (polyphagia), unexplained weight loss, fatigue, and blurred vision. Children may present in diabetic ketoacidosis (DKA) with nausea, vomiting, dehydration and rapid breathing.</p>
                          <h4 class="font-semibold text-cyan-800 mb-2">Diagnosis:</h4>
                          <p class="mb-4">Blood tests confirm hyperglycemia. Diagnostic criteria are the same as other types: an A1C ≥6.5%, fasting glucose ≥126 mg/dL (7.0 mmol/L), or 2-hour OGTT ≥200 mg/dL. In addition, testing for autoantibodies (e.g. GAD, IA-2) distinguishes T1D from type 2. C-peptide levels are low or undetectable, reflecting lack of insulin.</p>
                          <h4 class="font-semibold text-cyan-800 mb-2">Treatment:</h4>
                          <p class="mb-4">Lifelong insulin replacement is required. This can be delivered via multiple daily injections or an insulin pump (continuous subcutaneous infusion). Modern technologies (insulin pumps with continuous glucose monitors) form “artificial pancreas” systems that automatically adjust insulin dosing. For example, “smart” insulin-pump systems linked to smartphone apps can help maintain glucose in range. Medications may include rapid- and long-acting insulins; adjunct therapies like metformin are sometimes used. In late 2023 the FDA approved **teplizumab** (Tzield), a monoclonal antibody that can delay progression from preclinical autoimmunity to symptomatic T1D by about 2 years – a milestone in immunotherapy. Research also explores β-cell replacement: recent stem-cell transplants have enabled some patients to produce their own insulin again.</p>
                          <h4 class="font-semibold text-cyan-800 mb-2">Lifestyle and Diet:</h4>
                          <p class="mb-4">Patients must balance insulin doses with diet and exercise. Carbohydrate intake is carefully counted to dose insulin. A healthy diet (rich in complex carbs, fiber, and low in simple sugars/fats) and regular activity support stable glucose levels. Education on hypoglycemia prevention (carrying fast-acting glucose) is essential.</p>
                          <h4 class="font-semibold text-cyan-800 mb-2">Prevention:</h4>
                          <p class="mb-4">There is currently no established way to prevent type 1 diabetes. Research into vaccines or immune-modifying therapies is ongoing (e.g. trials of oral insulin and immune therapies).</p>
                          <h4 class="font-semibold text-cyan-800 mb-2">Long-term Complications:</h4>
                          <p class="mb-4">Chronic T1D causes **microvascular damage** (retinopathy, nephropathy, neuropathy) and **macrovascular disease** (heart attack, stroke). Proper glucose control can delay complications, but lifelong risk remains high if control is poor.</p>`
            },
            type2: {
                title: 'Type 2 Diabetes Mellitus (T2D): Insulin Resistance & Beta-Cell Dysfunction',
                content: `<p class="mb-4">Type 2 is the most common form of diabetes (accounting for over <strong>95%</strong> of cases). It occurs when the body becomes resistant to insulin or doesn't produce enough. Formerly known as non-insulin-dependent or adult-onset diabetes, it is now increasingly seen in children due to rising obesity rates. It arises from **insulin resistance** (in muscle/fat) coupled with progressive pancreatic β-cell dysfunction. Initially, the pancreas makes extra insulin, but over time, it cannot keep up.</p>
                          <h4 class="font-semibold text-cyan-800 mb-2">Causes and Risk Factors:</h4>
                          <p class="mb-4">Major risk factors are **obesity** and **physical inactivity**, which drive insulin resistance. Genetics and family history play roles. Demographic changes (aging populations, urbanization) and poor diet (high-calorie, high-sugar intake) contribute to rising T2D rates. Certain ethnicities (e.g., **South Asian, African descent**) have higher susceptibility. T2D is largely preventable – lifestyle changes (weight loss, exercise) significantly reduce risk, as demonstrated by diabetes prevention trials.</p>
                          <h4 class="font-semibold text-cyan-800 mb-2">Symptoms:</h4>
                          <p class="mb-4">Onset is usually insidious. Many patients are asymptomatic early on. Classic symptoms mirror type 1 (polyuria, polydipsia, fatigue), but often milder. **Acanthosis nigricans** (darkened skin in folds) may indicate insulin resistance. Frequently, type 2 is first detected on routine screening or when complications emerge (e.g., vision changes).</p>
                          <h4 class="font-semibold text-cyan-800 mb-2">Diagnosis:</h4>
                          <p class="mb-4">Same glucose criteria as T1D (A1C ≥6.5%, fasting glucose ≥126 mg/dL, or 2-hour OGTT ≥200 mg/dL). Because type 2 often develops slowly, screening with fasting glucose or A1C is common in adults with risk factors (overweight, family history, age >35, etc.). Oral glucose tolerance testing (OGTT) is used in ambiguous cases and in pregnancy screening.</p>
                          <h4 class="font-semibold text-cyan-800 mb-2">Treatment:</h4>
                          <p class="mb-4">Management is staged. Initially, **lifestyle intervention** (dietary modification, weight loss, exercise) is recommended. First-line medication is typically **metformin**. If glycemic targets are unmet, additional oral or injectable medications are added. Many modern drugs not only lower glucose but reduce cardiovascular risk or cause weight loss. Key classes include: **GLP-1 receptor agonists** (e.g., liraglutide, semaglutide) – incretin mimetics that increase insulin and suppress glucagon, often causing weight loss. **Dual/triple incretin agonists** (e.g., **tirzepatide** (Mounjaro), which activates both GLP-1 and GIP receptors. It provides superior blood-sugar control and weight loss compared to prior drugs. (Several triple agonists are in development.) **SGLT2 inhibitors** (e.g., empagliflozin) – increase urinary glucose excretion, reducing blood sugar and risk of heart failure/kidney disease. Other oral agents: sulfonylureas, thiazolidinediones, DPP-4 inhibitors, etc. Eventually, many patients may require insulin therapy (injections or pump) to achieve control. Technology (CGMs, insulin pumps) is increasingly used in type 2 as well.</p>
                          <h4 class="font-semibold text-cyan-800 mb-2">Lifestyle and Diet:</h4>
                          <p class="mb-4">Patients must balance insulin doses with diet and exercise. Carbohydrate intake is carefully counted to dose insulin. A healthy diet (rich in complex carbs, fiber, and low in simple sugars/fats) and regular activity support stable glucose levels. Education on hypoglycemia prevention (carrying fast-acting glucose) is essential.</p>
                          <h4 class="font-semibold text-cyan-800 mb-2">Prevention:</h4>
                          <p class="mb-4">Type 2 diabetes can often be prevented or delayed. In at-risk individuals (prediabetes), interventions like the **Diabetes Prevention Program** (diet and exercise counseling) can reduce progression by ~58%. Maintaining a healthy weight and active lifestyle remain the cornerstone of prevention.</p>
                          <h4 class="font-semibold text-cyan-800 mb-2">Long-term Complications:</h4>
                          <p class="mb-4">Like T1D, chronic hyperglycemia in T2D leads to microvascular (retinopathy, nephropathy, neuropathy) and macrovascular (coronary artery disease, stroke) complications. In fact, the majority of diabetes morbidity and mortality arises from cardiovascular disease. Controlling blood pressure, lipids, and glucose can greatly mitigate these risks.</p>`
            },
            gestational: {
                title: 'Gestational Diabetes Mellitus (GDM): During Pregnancy',
                content: `<p class="mb-4">Gestational diabetes (GDM) develops in some women during pregnancy, typically screened for at 24–28 weeks with an oral glucose tolerance test. Hormones made by the placenta can cause insulin resistance. If the pancreas can't make enough extra insulin, GDM occurs.</p>
                          <h4 class="font-semibold text-cyan-800 mb-2">Causes and Risk Factors:</h4>
                          <p class="mb-4">Develops when the pancreas cannot make enough extra insulin to overcome pregnancy-related insulin resistance. **Risk factors:** overweight, history of GDM, polycystic ovary syndrome, or family history of diabetes.</p>
                          <h4 class="font-semibold text-cyan-800 mb-2">Symptoms:</h4>
                          <p class="mb-4">Often none (detected by screening), but may include excessive thirst or urination.</p>
                          <h4 class="font-semibold text-cyan-800 mb-2">Diagnosis:</h4>
                          <p class="mb-4">Elevated glucose on OGTT in pregnancy.</p>
                          <h4 class="font-semibold text-cyan-800 mb-2">Treatment:</h4>
                          <p class="mb-4">Diet and exercise are first-line; insulin is safe and used if glucose targets are not met (some oral agents are also used in pregnancy).</p>
                          <h4 class="font-semibold text-cyan-800 mb-2">Lifestyle and Diet:</h4>
                          <p class="mb-4">Balanced diet with controlled carbohydrate portions; moderate exercise as approved by obstetrician.</p>
                          <h4 class="font-semibold text-cyan-800 mb-2">Prevention:</h4>
                          <p class="mb-4">Losing excess weight and staying active before and between pregnancies can reduce risk.</p>
                          <h4 class="font-semibold text-cyan-800 mb-2">Complications:</h4>
                          <p class="mb-4">GDM increases risks of high birth-weight infants, birth injuries, and neonatal hypoglycemia. Mothers have ~50% risk of developing T2D later in life, and children face higher risk of obesity and diabetes.</p>`
            },
            other: {
                title: 'Other Forms of Diabetes',
                content: `<p class="mb-4">Beyond the main types, other specific forms of diabetes exist, each with unique causes and presentations. These include:</p>
                          <div class="grid grid-cols-1 md:grid-cols-2 gap-4">
                            <div class="p-4 bg-slate-50 rounded-lg border">
                                <h4 class="font-semibold text-cyan-800 mb-2">MODY (Maturity-Onset Diabetes of the Young):</h4>
                                <p class="text-slate-600 text-sm">A group of **monogenic** (single-gene) diabetes subtypes usually appearing in youth or early adulthood. MODY often masquerades as Type 1 or 2, but patients may not require insulin (many respond to sulfonylureas). Genetic testing can identify specific MODY types for targeted management.</p>
                            </div>
                            <div class="p-4 bg-slate-50 rounded-lg border">
                                <h4 class="font-semibold text-cyan-800 mb-2">LADA (Latent Autoimmune Diabetes in Adults):</h4>
                                <p class="text-slate-600 text-sm">Often called “type 1.5,” LADA is adult-onset autoimmune diabetes. Patients have pancreatic autoantibodies (like T1D) but a slower progression, initially maintaining some insulin secretion. They may be managed like type 2 initially, but usually require insulin within a few years. LADA accounts for a minority of adult diabetics (estimates ~2–10%).</p>
                            </div>
                            <div class="p-4 bg-slate-50 rounded-lg border col-span-1 md:col-span-2">
                                <h4 class="font-semibold text-cyan-800 mb-2">Secondary Diabetes:</h4>
                                <p class="text-slate-600 text-sm">Occurs due to other conditions or treatments. For example, chronic pancreatitis, cystic fibrosis, or pancreatic surgery can impair insulin production (**“type 3c”** diabetes). Endocrine disorders (e.g., Cushing’s syndrome, acromegaly) and certain medications (glucocorticoids, some antipsychotics) can cause hyperglycemia. Management involves treating the underlying cause and standard diabetes therapies.</p>
                            </div>
                            <div class="p-4 bg-slate-50 rounded-lg border col-span-1 md:col-span-2">
                                <h4 class="font-semibold text-cyan-800 mb-2">Impaired Glucose Tolerance (IGT) and Impaired Fasting Glycaemia (IFG):</h4>
                                <p class="text-slate-600 text-sm">These are intermediate conditions with a high risk of progressing to Type 2 diabetes, though progression is not inevitable, offering opportunities for intervention. A recent development is the formal classification of "type 5 diabetes," linked to malnutrition, indicating evolving understandings of diabetes subtypes.</p>
                            </div>
                          </div>`
            }
        },
        management: {
             lifestyle: {
                title: 'Cornerstone of Care: Healthy Living',
                content: `<div class="grid md:grid-cols-2 gap-6">
                            <div>
                                <h4 class="font-semibold mb-2 text-lg text-cyan-800">Dietary Management</h4>
                                <p class="mb-2">A balanced diet is crucial. The "Plate Method" is a simple guide:</p>
                                <ul class="list-disc list-inside space-y-1 text-slate-600">
                                    <li><strong>Low-glycemic index foods</strong>.</li>
                                    <li><strong>Carb counting</strong> (for Type 1).</li>
                                    <li><strong>Plate method</strong>: <strong>½ Non-starchy veg</strong>, <strong>¼ Lean protein</strong>, <strong>¼ Carbohydrate foods</strong>.</li>
                                    <li>Reduced-calorie diets (for Type 2) are advised.</li>
                                </ul>
                                <p class="mt-2">Weight loss of even 5–10% of body weight often improves glycemic control. The American Diabetes Association (ADA) highlights the importance of healthy lifestyle changes for managing diabetes effectively.</p>
                            </div>
                            <div>
                                <h4 class="font-semibold mb-2 text-lg text-cyan-800">Physical Activity & Other Factors</h4>
                                 <p class="mb-2">Exercise improves insulin sensitivity and helps control weight. Aim for:</p>
                                <ul class="list-disc list-inside space-y-1 text-slate-600">
                                    <li><strong>150+ minutes/week</strong> of moderate aerobic activity (e.g., brisk walking, swimming).</li>
                                    <li><strong>2-3 sessions/week</strong> of resistance training (weights).</li>
                                </ul>
                                <p class="mt-2"><strong>Sleep/Stress:</strong> Poor sleep increases cortisol, which can lead to insulin resistance. All patients benefit from routine physical activity, smoking cessation, and control of blood pressure and lipids (often requiring statin therapy in older diabetics). The NIDDK notes that Type 2 diabetes can be prevented or delayed by losing weight if overweight, being active for 30 minutes most days, and following a reduced-calorie eating plan.</p>
                            </div>
                         </div>`
            },
            medication: {
                title: 'Pharmacological Support for Type 2 Diabetes',
                content: `<p class="mb-4">When lifestyle changes aren't enough, various oral or injectable medications can help manage Type 2 diabetes. They work in different ways to lower blood sugar. Combination regimens are common. Type 2 diabetes may involve medications like **metformin**, **sulfonylureas**, **SGLT-2 inhibitors**, alongside blood pressure medications and statins.</p>
                         <div class="grid sm:grid-cols-2 lg:grid-cols-3 gap-4 text-sm">
                            <div class="p-4 bg-slate-50 rounded-lg border"><strong>Metformin:</strong> Often first-line. Improves insulin sensitivity and reduces glucose production by the liver.</div>
                            <div class="p-4 bg-slate-50 rounded-lg border"><strong>SGLT2 Inhibitors:</strong> (e.g., empagliflozin, **Jardiance**) – increase urinary glucose excretion, reducing blood sugar and risk of heart failure/kidney disease.</div>
                            <div class="p-4 bg-slate-50 rounded-lg border"><strong>GLP-1 Agonists:</strong> (e.g., liraglutide, semaglutide, **Ozempic**) – incretin mimetics that slow digestion, boost insulin, and often cause weight loss.</div>
                            <div class="p-4 bg-slate-50 rounded-lg border"><strong>Dual/Triple Incretin Agonists:</strong> (e.g., **Tirzepatide** (Mounjaro)) activates both GLP-1 and GIP receptors, providing superior control and weight loss.</div>
                            <div class="p-4 bg-slate-50 rounded-lg border"><strong>DPP-4 Inhibitors:</strong> Help the body continue to make its own insulin by blocking an enzyme that breaks down incretins.</div>
                            <div class="p-4 bg-slate-50 rounded-lg border"><strong>Sulfonylureas:</strong> Stimulate the pancreas to release more insulin.</div>
                            <div class="p-4 bg-slate-50 rounded-lg border"><strong>Thiazolidinediones (TZDs):</strong> Improve the body's sensitivity to insulin.</div>
                         </div>
                         <p class="mt-4 text-xs text-slate-500">This is not an exhaustive list. Treatment is highly individualized and determined by a healthcare provider.</p>`
            },
            insulin: {
                title: 'Insulin Therapy and Technology',
                content: `<p class="mb-4">Insulin remains the cornerstone for Type 1 diabetes and advanced Type 2. New insulin formulations (ultra-long-acting, ultra-rapid-acting) improve flexibility. Research is ongoing on “smart insulins” that activate only when blood glucose is high.</p>
                        <div class="chart-container" style="height: 300px; max-height: 40vh;">
                            <canvas id="insulinChart"></canvas>
                        </div>
                        <p class="mt-4 text-xs text-slate-500">The chart above provides a simplified visual of insulin action profiles. The goal of therapy is to mimic the body's natural insulin patterns. Diabetics often use **continuous glucose monitors (CGMs)** (e.g., Dexcom, Libre) and **insulin pumps** (e.g., t:slim, Omnipod); **hybrid closed-loop (“artificial pancreas”) systems** are FDA-approved and can automatically adjust insulin delivery, easing day-to-day control.</p>`
            },
        },
        complications: {
            brain: {
                title: "Brain & Cognitive Health",
                content: "Diabetes, particularly Type 2, increases the risk of Alzheimer's disease and other dementias. Poorly controlled blood sugar is linked to a more rapid decline in memory and cognitive skills. It also elevates the risk of stroke (**macrovascular** complication)."
            },
            eyes: {
                title: "Eye Damage (Retinopathy)",
                content: "Diabetes is a leading cause of blindness in adults. High blood sugar can damage the delicate blood vessels in the retina (**diabetic retinopathy** - a **microvascular** complication). It also increases the risk of cataracts and glaucoma. Treatment: Laser therapy, anti-VEGF injections."
            },
            heart: {
                title: "Cardiovascular Disease",
                content: "This is the most common cause of death for people with diabetes. The condition dramatically increases the risk of heart attack, stroke, high blood pressure, and atherosclerosis (narrowing of the arteries) (**macrovascular** complication). It is linked to 1 in 2 cardiovascular deaths."
            },
            kidneys: {
                title: "Kidney Disease (Nephropathy)",
                content: "About 1 in 3 adults with diabetes has kidney disease. Diabetes damages the tiny filtering units in the kidneys over time, which can lead to kidney failure requiring dialysis or a transplant (**microvascular** complication). It contributes to 530,000 kidney disease deaths annually. Treatment: ACE inhibitors/SGLT2 inhibitors."
            },
            nerves: {
                title: "Nerve Damage (Neuropathy)",
                content: "Affecting up to half of people with diabetes, nerve damage can cause tingling, numbness, burning, or pain, usually starting in the feet or hands (**microvascular** complication). It can also affect digestion, heart rate, and other bodily functions."
            },
            feet: {
                title: "Foot Complications",
                content: "A combination of nerve damage (loss of feeling - **neuropathy**) and poor blood flow (**peripheral arterial disease** - a **macrovascular** complication) increases the risk of serious foot problems. Minor cuts or blisters can go unnoticed, become infected, and lead to ulcers and potential amputation if not treated promptly. Daily foot checks are crucial!"
            }
        }
    };

    let diagnosisChartInstance;
    let insulinChartInstance;

    const typeTabButtons = document.querySelectorAll('.type-tab-button');
    const typeContentArea = document.getElementById('type-content-area');
    const managementTabButtons = document.querySelectorAll('.management-tab-button');
    const managementContentArea = document.getElementById('management-content-area');
    const testSelector = document.getElementById('test-selector');
    const complicationDots = document.querySelectorAll('.complication-dot');
    const complicationInfoArea = document.getElementById('complication-info-area');

    const insulinSimulateBtn = document.getElementById('simulate-insulin-btn');
    const glucoseParticle = document.getElementById('glucose-particle');
    const insulinKey = document.getElementById('insulin-key');
    const cellWall = document.getElementById('cell-wall');
    const cellLock = document.getElementById('cell-lock');
    const diagramExplanation = document.getElementById('diagram-explanation');
    const diabetesStateInfo = document.getElementById('diabetes-state-info');
    let isSimulated = false;

    // AI Chat elements
    const chatWindow = document.getElementById('chat-window');
    const chatInput = document.getElementById('chat-input');
    const sendChatBtn = document.getElementById('send-chat-btn');
    const loadingIndicator = document.getElementById('loading-indicator');

    // Chat history for multi-turn conversations
    let chatHistory = [{
        role: "model",
        parts: [{ text: "Hello! I'm here to help you with information on diabetes treatments and self-management. What would you like to know?" }]
    }];

    // API Key (Canvas will inject this at runtime)
    const apiKey = ""; 

    function resetSimulation() {
        glucoseParticle.style.transform = 'translateX(0) scale(1)';
        glucoseParticle.style.opacity = '1';
        insulinKey.style.transform = 'translateX(0)';
        cellWall.style.borderColor = '#d1d5db';
        cellLock.style.backgroundColor = '#9ca3af';
        diagramExplanation.textContent = 'Press the button to see how insulin unlocks the cell for glucose.';
        insulinSimulateBtn.textContent = 'Simulate Insulin Action';
        diabetesStateInfo.classList.add('hidden');
        isSimulated = false;
    }

    insulinSimulateBtn.addEventListener('click', () => {
        if (isSimulated) {
            resetSimulation();
            return;
        }

        diagramExplanation.textContent = 'Insulin (I) travels to the cell...';
        insulinKey.style.transform = 'translateX(100px)';
        
        setTimeout(() => {
            diagramExplanation.textContent = '...and unlocks it, allowing glucose (G) to enter and provide energy!';
            cellLock.style.backgroundColor = '#06b6d4'; 
            cellWall.style.borderColor = '#06b6d4';
            glucoseParticle.style.transform = 'translateX(200px) scale(0)';
            glucoseParticle.style.opacity = '0';
        }, 1200);

        setTimeout(() => {
            diabetesStateInfo.classList.remove('hidden');
            insulinSimulateBtn.textContent = 'Reset Simulation';
            isSimulated = true;
        }, 2400);
    });

    function addMessageToChat(role, text) {
        const messageDiv = document.createElement('div');
        messageDiv.classList.add(role === 'user' ? 'user-message' : 'ai-message');
        messageDiv.textContent = text;
        chatWindow.appendChild(messageDiv);
        chatWindow.scrollTop = chatWindow.scrollHeight; // Scroll to bottom
    }

    async function sendChatMessage() {
        const userMessage = chatInput.value.trim();
        if (userMessage === '') return;

        addMessageToChat('user', userMessage);
        chatHistory.push({ role: "user", parts: [{ text: userMessage }] });
        chatInput.value = ''; // Clear input

        loadingIndicator.style.display = 'block';
        sendChatBtn.disabled = true;

        const promptPrefix = "You are a helpful assistant providing information on diabetes. Focus on either latest treatments/future advancements or self-management education/how individuals can stay updated, or general diabetes info. Keep responses informative and concise. Avoid medical advice. For 'college' assume self-education resources or formal education for healthcare professionals.\n";
        
        // Prepare payload with chat history
        const payload = { 
            contents: chatHistory,
            generationConfig: {
                maxOutputTokens: 500, // Limit response length for conciseness
                temperature: 0.7,
                topP: 0.9,
                topK: 40
            }
        };

        try {
            const apiUrl = `https://generativelanguage.googleapis.com/v1beta/models/gemini-2.0-flash:generateContent?key=${apiKey}`;
            const response = await fetch(apiUrl, {
                method: 'POST',
                headers: { 'Content-Type': 'application/json' },
                body: JSON.stringify(payload)
            });

            if (!response.ok) {
                const errorData = await response.json();
                console.error("API Error:", errorData);
                throw new Error(`API request failed with status ${response.status}: ${JSON.stringify(errorData)}`);
            }

            const result = await response.json();
            
            let aiResponseText = "Sorry, I couldn't get a response right now. Please try again later.";
            if (result.candidates && result.candidates.length > 0 &&
                result.candidates[0].content && result.candidates[0].content.parts &&
                result.candidates[0].content.parts.length > 0) {
                aiResponseText = result.candidates[0].content.parts[0].text;
            } else {
                console.warn("Unexpected API response structure:", result);
            }

            addMessageToChat('ai', aiResponseText);
            chatHistory.push({ role: "model", parts: [{ text: aiResponseText }] });

        } catch (error) {
            console.error("Error fetching AI response:", error);
            addMessageToChat('ai', 'There was an error processing your request. Please try again.');
        } finally {
            loadingIndicator.style.display = 'none';
            sendChatBtn.disabled = false;
        }
    }

    sendChatBtn.addEventListener('click', sendChatMessage);
    chatInput.addEventListener('keypress', (e) => {
        if (e.key === 'Enter' && !e.shiftKey) { // Allow Shift+Enter for new line
            e.preventDefault();
            sendChatMessage();
        }
    });

    function updateTypeContent(type) {
        const data = dataStore.types[type];
        if (data) {
            typeContentArea.innerHTML = `
                <h3 class="text-xl md:text-2xl font-bold text-cyan-800 mb-4">${data.title}</h3>
                <div class="prose prose-slate max-w-none text-slate-700">${data.content}</div>`;
        }
    }

    function updateManagementContent(tab) {
        const data = dataStore.management[tab];
        if (data) {
            managementContentArea.innerHTML = `
                <h3 class="text-xl md:text-2xl font-bold text-cyan-800 mb-4">${data.title}</h3>
                <div class="prose prose-slate max-w-none text-slate-700">${data.content}</div>`;
            
            if (tab === 'insulin') {
                // Ensure chart renders after content is in DOM
                setTimeout(createInsulinChart, 50); 
            }
        }
    }
    
    function createInsulinChart() {
        const ctx = document.getElementById('insulinChart');
        if (!ctx) return;

        if (insulinChartInstance) {
            insulinChartInstance.destroy();
        }

        const data = {
            labels: ['0h', '2h', '4h', '6h', '8h', '10h', '12h', '16h', '20h', '24h'],
            datasets: [
                {
                    label: 'Rapid-Acting',
                    data: [0, 2, 1, 0.5, 0, null, null, null, null, null],
                    borderColor: '#ef4444',
                    backgroundColor: '#ef444420',
                    fill: true,
                    tension: 0.4
                },
                {
                    label: 'Short-Acting',
                    data: [0, 1, 2, 1.5, 1, 0.5, 0, null, null, null],
                    borderColor: '#f97316',
                    backgroundColor: '#f9731620',
                    fill: true,
                    tension: 0.4
                },
                 {
                    label: 'Intermediate-Acting',
                    data: [0, 0, 1, 2, 2.5, 2, 1.5, 1, 0, null],
                    borderColor: '#22c55e',
                    backgroundColor: '#22c55e20',
                    fill: true,
                    tension: 0.4
                },
                 {
                    label: 'Long-Acting',
                    data: [0, 0.5, 0.8, 1, 1, 1, 1, 1, 1, 1],
                    borderColor: '#3b82f6',
                    backgroundColor: '#3b82f620',
                    fill: true,
                    tension: 0.2
                },
            ]
        };

        insulinChartInstance = new Chart(ctx, {
            type: 'line',
            data: data,
            options: {
                responsive: true,
                maintainAspectRatio: false,
                plugins: {
                    title: { display: true, text: 'Relative Insulin Action Over Time' },
                    legend: { position: 'bottom' },
                    tooltip: { mode: 'index', intersect: false,
                        callbacks: {
                            title: function(context) {
                                const hours = context[0].label.replace('h', '');
                                return `${hours} Hours`;
                            },
                            label: function(context) {
                                let label = context.dataset.label || '';
                                if (label) {
                                    label += ': ';
                                }
                                label += context.raw > 0 ? `${context.raw} effect` : 'No significant effect';
                                return label;
                            }
                        }
                    }
                },
                scales: {
                    y: {
                        title: { display: true, text: 'Relative Insulin Effect' },
                        beginAtZero: true,
                        ticks: { display: false }
                    },
                    x: {
                        title: { display: true, text: 'Hours After Injection' }
                    }
                },
                elements: {
                    point: { radius: 0 }
                }
            }
        });
    }

    function updateDiagnosisChart(test) {
        const ctx = document.getElementById('diagnosisChart');
        if (!ctx) return;

        const dataSets = {
            a1c: {
                labels: ['Normal', 'Prediabetes', 'Diabetes'],
                data: [5.7, 6.5, 10], 
                ranges: ['< 5.7%', '5.7% - 6.4%', '≥ 6.5%']
            },
            fpg: {
                labels: ['Normal', 'Prediabetes', 'Diabetes'],
                data: [100, 126, 200],
                ranges: ['< 100 mg/dL', '100-125 mg/dL', '≥ 126 mg/dL']
            },
            ogtt: {
                labels: ['Normal', 'Prediabetes', 'Diabetes'],
                data: [140, 200, 250],
                ranges: ['< 140 mg/dL', '140-199 mg/dL', '≥ 200 mg/dL']
            }
        };

        const selectedData = dataSets[test];

        if (diagnosisChartInstance) {
            diagnosisChartInstance.destroy();
        }

        diagnosisChartInstance = new Chart(ctx, {
            type: 'bar',
            data: {
                labels: selectedData.labels,
                datasets: [{
                    label: 'Test Value Range',
                    data: selectedData.data,
                    backgroundColor: [
                        'rgba(74, 222, 128, 0.6)', 
                        'rgba(251, 146, 60, 0.6)',
                        'rgba(239, 68, 68, 0.6)' 
                    ],
                    borderColor: [
                        'rgba(34, 197, 94, 1)',
                        'rgba(249, 115, 22, 1)',
                        'rgba(220, 38, 38, 1)'
                    ],
                    borderWidth: 1
                }]
            },
            options: {
                indexAxis: 'y',
                responsive: true,
                maintainAspectRatio: false,
                plugins: {
                    legend: { display: false },
                    tooltip: {
                        callbacks: {
                            label: function(context) {
                                let label = context.dataset.label || '';
                                if (label) {
                                    label += ': ';
                                }
                                label += selectedData.ranges[context.dataIndex];
                                return label;
                            }
                        }
                    }
                },
                scales: {
                    x: {
                        beginAtZero: true,
                        title: { display: true, text: testSelector.options[testSelector.selectedIndex].text },
                        ticks: {
                            callback: function(value) {
                                const maxLen = 16; 
                                if (typeof value === 'number') {
                                    value = value.toString();
                                }
                                if (value.length > maxLen) {
                                    return value.match(new RegExp('.{1,' + maxLen + '}', 'g'));
                                }
                                return value;
                            }
                        }
                    }
                }
            }
        });
    }

    function updateComplicationInfo(comp) {
        const data = dataStore.complications[comp];
        if (data) {
             complicationInfoArea.innerHTML = `
                <div class="p-6 bg-slate-100 rounded-lg fade-in">
                    <h3 class="text-xl font-bold text-cyan-800 mb-2">${data.title}</h3>
                    <p class="text-slate-600">${data.content}</p>
                </div>`;
        }
    }

    typeTabButtons.forEach(button => {
        button.addEventListener('click', () => {
            typeTabButtons.forEach(btn => btn.classList.remove('active'));
            button.classList.add('active');
            updateTypeContent(button.dataset.type);
            typeContentArea.classList.remove('fade-in');
            void typeContentArea.offsetWidth; // Trigger reflow
            typeContentArea.classList.add('fade-in');
        });
    });

    managementTabButtons.forEach(button => {
        button.addEventListener('click', () => {
            managementTabButtons.forEach(btn => btn.classList.remove('active'));
            button.classList.add('active');
            updateManagementContent(button.dataset.tab);
            managementContentArea.classList.remove('fade-in');
            void managementContentArea.offsetWidth; // Trigger reflow
            managementContentArea.classList.add('fade-in');
        });
    });

    complicationDots.forEach(dot => {
        dot.addEventListener('click', (e) => {
            complicationDots.forEach(d => d.classList.remove('active'));
            e.currentTarget.classList.add('active');
            updateComplicationInfo(e.currentTarget.dataset.comp);
        })
    });

    testSelector.addEventListener('change', (e) => {
        updateDiagnosisChart(e.target.value);
    });

    // Initial setup for default visible tabs and charts
    updateTypeContent('type2'); // Default to Type 2 tab
    updateManagementContent('lifestyle'); // Default to Lifestyle tab
    updateDiagnosisChart(testSelector.value); // Initialize diagnosis chart
    resetSimulation(); // Initialize insulin simulation
});
</script>

</body>
</html>
